DocDollars

Medacta USA, Inc.

TN · United States · Reporting entity ID 100000000078

Total reported 2019–2025
$54.3M
#163 of 2,960 reporting companies — 0.1% of all reported industry payments
$46.6M in general payments across 29,290 records, plus $7.74M in research funding across 655 records.

How it breaks down

General payments $46,555,206
Research funding $7,738,123

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Medacta USA, Inc. reported $54.3M to US doctors and teaching hospitals from 2019 to 2025, ranking #163 of 2,960 reporting companies. 14% of that was research funding and 86% general payments such as consulting, speaking, food and travel. 29,290 general payment records and 655 research records were filed.

Common questions about Medacta USA, Inc.

How much has Medacta USA, Inc. paid US doctors?

Medacta USA, Inc. reported $54,293,329 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $46,555,206 in general payments, $7,738,123 in research funding.

How does Medacta USA, Inc. rank among drug and device companies?

It ranks #163 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Medacta USA, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.